Our Investment Focus

Colorcon Ventures invests in and supports entrepreneurs developing transformational pharmaceutical industry solutions, through strategic relationships that create value for both Colorcon and our portfolio companies.

Our Investment Focus

Investment in innovative pharmaceutical industry solutions including:

  • Technologies to improve patient compliance and medication adherence
  • Solutions to authenticate dosage forms and reduce impact of diversion and counterfeiting of medications
  • Transformational technologies disrupting conventional dosage delivery pathways
  • Smart technologies for digital and personalized medicines
  • Breakthrough technologies and advanced manufacturing processes
  • Other intelligent solutions to address unmet needs in pharmaceutical technology or supply chains

Note: We are currently not investing in active pharmaceutical ingredient (API) or therapeutic molecule development

Stage

  • We are stage agnostic, but primarily focused on early and mid-stage investments

Size

  • $50 million fund
  • Typical investment size: $1-3 million initial investment
  • We reserve capital for future financing rounds
  • We aim to co-invest with top-tier venture capital investors, as a lead or follow-on investor